| Project/Area Number |
23791835
|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
| Research Field |
Obstetrics and gynecology
|
| Research Institution | Kyoto University |
Principal Investigator |
|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
| Keywords | 婦人科腫瘍学 / 卵巣癌 / 明細胞腺癌 / 糖代謝 / エピジェネティクス / 分子標的薬 / バイオインフォマティクス / 酸化ストレス / 代謝 |
| Research Abstract |
It is known that ovarian clear cell carcinoma (CCC), arising in endometriotic cyst under reactive oxygen species (ROS) condition, exclusively expresses HNF1 β . In this study, we found HNF1 β confers ROS resistance in CCC cells. Furthermore, HNF1 β increased glucose uptake through upregulation of GLUT 1 expression. HNF1 β and its downstream genes were upregulated in CCC by hypomethylation.
|